Related Experiment Videos
The major histocompatibility complex and its relationship to allergic disease
Annals of Allergy
|November 1, 1976
Summary
Mixed leukocyte culture (MLC) and cell-mediated lympholysis (CML) tests model allograft reactions for histocompatibility and immune function. A new primed LD typing (PLT) test defines major histocompatibility complex LD antigens via in vitro sensitization and restimulation.
Area of Science:
- Immunology
- Transplantation Science
Background:
- Mixed leukocyte culture (MLC) and cell-mediated lympholysis (CML) are established in vitro models for studying allograft rejection.
- These assays are crucial for histocompatibility testing in transplantation and evaluating immune system function.
Purpose of the Study:
- To introduce and describe the primed LD typing (PLT) test as a novel method for defining lymphocyte-defined (LD) antigens.
- To detail the application of MLC and CML tests in histocompatibility and immune function assays.
Main Methods:
- Utilizing peripheral blood lymphocytes as responding or stimulating cells in MLC and CML assays.
- Employing in vitro sensitization of lymphocytes to major histocompatibility complex LD antigens.
- Implementing restimulation of sensitized lymphocytes with test cells for antigen definition.
Main Results:
- MLC assays primarily identify proliferative responses to LD antigens of the major histocompatibility complex.
- CML assays target cytotoxic responses against the serologically-defined (SD) antigens of the major histocompatibility complex.
- The PLT test enables precise definition of LD antigens through a two-step sensitization and restimulation process.
Conclusions:
- The PLT test offers a refined approach to characterizing LD antigens, complementing existing MLC and CML methodologies.
- These in vitro models are vital tools for understanding immune responses relevant to transplantation and immune diagnostics.